Desipramine facilitation of initial cocaine abstinence

Archives of General Psychiatry
F H GawinC Morgan

Abstract

We conducted a double-blind, random assignment, six-week comparison of desipramine hydrochloride (n = 24), lithium carbonate (n = 24), and placebo (n = 24) treatments for cocaine dependence. Subjects were 72 outpatient cocaine abusers who met DSM-III-R dependence criteria for cocaine but not for other substance abuse. Subjects in each treatment group were similar in history of cocaine and other substance abuse, cocaine craving, sociodemographics, and other psychiatric comorbidity. Desipramine, compared with both other treatments, substantially decreased cocaine use. Lithium treatment outcome did not differ from that of placebo. Desipramine-treated subjects attained contiguous periods of abstinence substantially more frequently than subjects receiving lithium or placebo. Fifty-nine percent of the desipramine-treated subjects were abstinent for at least three to four consecutive weeks during the six-week study period, compared with 17% for placebo and 25% for lithium. Cocaine craving reductions were also substantially greater in the desipramine-treated subjects. Establishment of initial abstinence is the first stage in recovery from cocaine dependence. Our findings indicate that desipramine is an effective general treatment, for ...Continue Reading

Citations

Oct 31, 2012·Journal of Consulting and Clinical Psychology·Paul Crits-ChristophRobert Gallop
Dec 21, 2000·Current Psychiatry Reports·G O'Leary, R D Weiss
Feb 14, 2007·Journal of Consulting and Clinical Psychology·Robert J GallopMichael E Thase
Jul 30, 2002·Addiction·Maurício Silva de LimaMichael Farrell
Nov 1, 1995·Journal of Substance Abuse Treatment·A OlivetoD Ziedonis
Jan 1, 1993·Journal of Substance Abuse Treatment·T A KostenB J Rounsaville
Jan 1, 1992·Journal of Substance Abuse Treatment·P J Frawley, J W Smith
Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Jul 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·S G SirisJ M Alvir
Dec 1, 1990·Psychiatry Research·K R AlperE R John
May 23, 2002·Biological Psychiatry·William A CarlezonPerry F Renshaw
Mar 1, 1991·Biological Psychiatry·W A KehoeA F Harralson
Jun 6, 2003·Journal of Abnormal Psychology·Michael R HuffordJohn C Caruso
Jul 1, 1991·Behavioral Sciences & the Law·D H Fishbein
Jan 1, 1991·Psychopharmacology·M E Reith, C T Fischette
Jan 1, 1993·Psychopharmacology·S R Tella, S R Goldberg
Aug 1, 1995·Pharmacology, Biochemistry, and Behavior·S R Tella
Jun 1, 1996·Pharmacology, Biochemistry, and Behavior·S R Tella
Jul 1, 1997·Pharmacology, Biochemistry, and Behavior·M L Stitzer, S L Walsh
Aug 1, 1990·Pharmacology, Biochemistry, and Behavior·R W FoltinC Nautiyal
Oct 6, 2000·General Hospital Psychiatry·M A Adler Cohen, J M Jacobson
Jan 1, 1994·Neuroscience and Biobehavioral Reviews·J M Witkin
May 17, 2005·Neuroscience and Biobehavioral Reviews·Alasdair M Barr, Athina Markou
Apr 1, 1992·Journal of Abnormal Child Psychology·D L PoggeP D Harvey
Dec 5, 2015·Expert Opinion on Pharmacotherapy·Jean-Michel AzorinRaoul Belzeaux
May 1, 1993·The International Journal of the Addictions·R R GaineyR F Catalano
Mar 1, 1991·The International Journal of the Addictions·V AgostiF M Quitkin
Feb 1, 1996·The American Journal of Drug and Alcohol Abuse·V AgostiK Ocepeck-Welikson
May 1, 1996·The American Journal of Drug and Alcohol Abuse·R D WeissC Hufford
Jan 1, 1990·The American Journal of Drug and Alcohol Abuse·T R KostenP Jatlow
Sep 1, 1991·The American Journal of Drug and Alcohol Abuse·K M CarrollF H Gawin
Jan 1, 1992·The American Journal of Drug and Alcohol Abuse·T A KostenT R Kosten
Aug 1, 1995·The American Journal of Drug and Alcohol Abuse·L CoviC A Haertzen
Jun 1, 1996·Alcoholism, Clinical and Experimental Research·D DavidsonE Fitz
Mar 31, 2005·Human Psychopharmacology·N SzermanUNKNOWN Grupo de Estudio del Uso de Reboxetina en Dependencia a Cocaina
Mar 1, 2012·Behavioural Brain Research·Maria do Carmo de Oliveira CitóFrancisca Cléa Florenço de Sousa
Jan 1, 1991·Journal of Substance Abuse·R A RawsonW Ling

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.